Lv5
1125 积分 2021-05-28 加入
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
5个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
5个月前
已完结
Post-Progression treatment options after CDK4/6 inhibitors in hormone Receptor-Positive HER2-Negative metastatic breast cancer
5个月前
已完结
Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells
7个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
7个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
7个月前
已完结
Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4
7个月前
已完结
Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells
7个月前
已完结
GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration
7个月前
已完结
Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect
7个月前
已完结
皖公网安备34019202002308
